In re Ciprofloxacin Hydrochloride Antitrust Litigation

Case Number: CLB0207

Date: 10.15.2008

Citation: 88 U.S.P.Q.2d 1801 (Fed. Cir. 2008)

In the absence of evidence of fraud before the PTO or sham litigation, the court need not consider the validity of a patent in the antitrust analysis of a settlement agreement involving a reverse payment.

Download PDF Return to Case Law Briefs Main Page